
PMC:6640909 / 42037-42302
Annnotations
TEST0
{"project":"TEST0","denotations":[{"id":"31100109-232-238-7390","span":{"begin":244,"end":246},"obj":"[\"23352391\"]"},{"id":"31100109-13-20-7391","span":{"begin":252,"end":255},"obj":"[\"24075484\"]"},{"id":"31100109-22-29-7392","span":{"begin":261,"end":264},"obj":"[\"20929978\"]"}],"text":"Heart failure medication (diuretic agents, angiotensin converting enzyme inhibitor or angiotensin receptor blocker, beta-blockers and mineralocorticoid receptor antagonists) should be considered during mechanical circulatory support. IIa C [71, 377–384, 393–400]"}
MyTest
{"project":"MyTest","denotations":[{"id":"31100109-23352391-28905450","span":{"begin":244,"end":246},"obj":"23352391"},{"id":"31100109-24075484-28905451","span":{"begin":252,"end":255},"obj":"24075484"},{"id":"31100109-20929978-28905452","span":{"begin":261,"end":264},"obj":"20929978"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Heart failure medication (diuretic agents, angiotensin converting enzyme inhibitor or angiotensin receptor blocker, beta-blockers and mineralocorticoid receptor antagonists) should be considered during mechanical circulatory support. IIa C [71, 377–384, 393–400]"}
0_colil
{"project":"0_colil","denotations":[{"id":"31100109-23352391-7390","span":{"begin":244,"end":246},"obj":"23352391"},{"id":"31100109-24075484-7391","span":{"begin":252,"end":255},"obj":"24075484"},{"id":"31100109-20929978-7392","span":{"begin":261,"end":264},"obj":"20929978"}],"text":"Heart failure medication (diuretic agents, angiotensin converting enzyme inhibitor or angiotensin receptor blocker, beta-blockers and mineralocorticoid receptor antagonists) should be considered during mechanical circulatory support. IIa C [71, 377–384, 393–400]"}
2_test
{"project":"2_test","denotations":[{"id":"31100109-23352391-28905450","span":{"begin":244,"end":246},"obj":"23352391"},{"id":"31100109-24075484-28905451","span":{"begin":252,"end":255},"obj":"24075484"},{"id":"31100109-20929978-28905452","span":{"begin":261,"end":264},"obj":"20929978"}],"text":"Heart failure medication (diuretic agents, angiotensin converting enzyme inhibitor or angiotensin receptor blocker, beta-blockers and mineralocorticoid receptor antagonists) should be considered during mechanical circulatory support. IIa C [71, 377–384, 393–400]"}